BDX
Price
$183.32
Change
+$2.73 (+1.51%)
Updated
Sep 26, 01:30 PM (EDT)
Capitalization
51.76B
41 days until earnings call
SRDX
Price
$29.93
Change
-$0.89 (-2.89%)
Updated
Sep 26, 01:28 PM (EDT)
Capitalization
440.65M
40 days until earnings call
Interact to see
Advertisement

BDX vs SRDX

Header iconBDX vs SRDX Comparison
Open Charts BDX vs SRDXBanner chart's image
Becton Dickinson and
Price$183.32
Change+$2.73 (+1.51%)
Volume$100
Capitalization51.76B
Surmodics
Price$29.93
Change-$0.89 (-2.89%)
Volume$2.52K
Capitalization440.65M
BDX vs SRDX Comparison Chart in %
Loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDX vs. SRDX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and SRDX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BDX: $180.59 vs. SRDX: $30.82)
Brand notoriety: BDX and SRDX are both not notable
BDX represents the Pharmaceuticals: Other, while SRDX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BDX: 89% vs. SRDX: 62%
Market capitalization -- BDX: $51.76B vs. SRDX: $440.65M
BDX [@Pharmaceuticals: Other] is valued at $51.76B. SRDX’s [@Medical/Nursing Services] market capitalization is $440.65M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, BDX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 4 TA indicator(s) are bullish while SRDX’s TA Score has 5 bullish TA indicator(s).

  • BDX’s TA Score: 4 bullish, 5 bearish.
  • SRDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BDX is a better buy in the short-term than SRDX.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а -4.13% price change this week, while SRDX (@Medical/Nursing Services) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.41%. For the same industry, the average monthly price growth was -3.48%, and the average quarterly price growth was +8.40%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +9.32%.

Reported Earning Dates

BDX is expected to report earnings on Nov 06, 2025.

SRDX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.41% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($51.8B) has a higher market cap than SRDX($441M). SRDX has higher P/E ratio than BDX: SRDX (43.23) vs BDX (33.01). BDX YTD gains are higher at: -19.117 vs. SRDX (-22.172). BDX has higher annual earnings (EBITDA): 4.92B vs. SRDX (-2.74M). SRDX has less debt than BDX: SRDX (32.6M) vs BDX (19.3B). BDX has higher revenues than SRDX: BDX (21.4B) vs SRDX (121M).
BDXSRDXBDX / SRDX
Capitalization51.8B441M11,746%
EBITDA4.92B-2.74M-179,256%
Gain YTD-19.117-22.17286%
P/E Ratio33.0143.2376%
Revenue21.4B121M17,686%
Total CashN/A32.7M-
Total Debt19.3B32.6M59,202%
FUNDAMENTALS RATINGS
BDX vs SRDX: Fundamental Ratings
BDX
SRDX
OUTLOOK RATING
1..100
6556
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8295
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
8393
SEASONALITY SCORE
1..100
5039

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (19) in the Medical Specialties industry is significantly better than the same rating for SRDX (94). This means that BDX’s stock grew significantly faster than SRDX’s over the last 12 months.

BDX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's SMR Rating (82) in the Medical Specialties industry is in the same range as SRDX (95). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's Price Growth Rating (62) in the Medical Specialties industry is in the same range as SRDX (63). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's P/E Growth Rating (83) in the Medical Specialties industry is in the same range as SRDX (93). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXSRDX
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
36%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
40%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
36%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 9 days ago
45%
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
Bearish Trend 1 day ago
36%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUWAX37.79N/A
N/A
DWS Core Equity A
MUOAX33.21N/A
N/A
Morgan Stanley Instl US Core A
ASCFX26.17N/A
N/A
Virtus Small-Cap R6
BAUAX29.59N/A
N/A
Brown Advisory Small-Cap Fdmtl Val Adv
FFAFX86.99-0.84
-0.96%
American Funds Growth Fund of Amer 529F3

SRDX and

Correlation & Price change

A.I.dvisor tells us that SRDX and BDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRDX and BDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+1.18%
BDX - SRDX
32%
Poorly correlated
-2.93%
ALGN - SRDX
31%
Poorly correlated
-2.57%
BLCO - SRDX
29%
Poorly correlated
-4.26%
ATRC - SRDX
28%
Poorly correlated
-2.94%
MBOT - SRDX
26%
Poorly correlated
-1.79%
More